The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
4 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $6,016,129 in first-year total cost, median $824,376.
Most frequent study sections
- HIV Immunopathogenesis and Vaccine Development Study Section[HIVD]3
- Special Emphasis Panel[ZRG1 DCAI-D (03)]1
Most frequent institutions
- FRED HUTCHINSON CANCER CENTER1
- J. DAVID GLADSTONE INSTITUTES1
- SCRIPPS RESEARCH INSTITUTE, THE1
- UNIVERSITY OF PENNSYLVANIA1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2025 | Transforming HIV vaccine design with a hybrid technology that leverages features of mRNA and protein nanoparticle platforms1R01AI191341-01 | HOFFMANN, MAGNUS ADRIAN GERO | J. DAVID GLADSTONE INSTITUTES, CA | $3,559,750 | ZRG1 |
| 2024 | Deep Learning-based Protein Design of HIV-1 Env GP120 Core Immunogens for CD4 Binding Site Germline Targeting1R01AI183406-01 | ALDON, YOANNPANCERA, MARIE | FRED HUTCHINSON CANCER CENTER, WA | $832,117 | HIVD |
| 2024 | Leveraging membrane Env liposome vaccine design to elicit multi-target cross-neutralization of HIV1R01AI183472-01 | ZWICK, MICHAEL B | SCRIPPS RESEARCH INSTITUTE, THE, CA | $816,634 | HIVD |
| 2024 | SHIV-guided design of novel HIV-1 fusion peptide immunogens1R01AI183332-01 | SHAW, GEORGE M | UNIVERSITY OF PENNSYLVANIA, PA | $807,628 | HIVD |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.